Comment & analysis
Clinton’s anti-drugmaker rhetoric may win votes, but does it threaten our long-term health?
Clinton, who named drug companies among her enemies in this week's debate, is pushing policies that could hamper the flow of new medicines, argues Chris Ford in The Conversation.
How data empowered the economic individual and gained a Nobel for Angus Deaton
This year's award recognises the value of micro analysis and good, old-fashioned legwork, argues Dr Vincent O'Sullivan.
Too many smart northerners leave for London
In the Independent, LUMS's Dr Vincent O'Sullivan and Dr Hakim Yadi, Chief Executive of the Northern Health Science Alliance, argue that any Northern Powerhouse must try to bring talented graduates back from the capital.Read the article on The Independent website
Why we should worry less about rising CEO pay
Swarnodeep Homroy argues that it is compensation for the risk of dismissal, rather than greed, which is behind rising CEO salaries.
Lessons from VW: courage, climate change and the C-suite
Professor Gail Whiteman, from the Pentland Centre for Sustainability in Business, discusses the emissions scandal.
Three industries that will be hit by Arctic change
In her latest blog post for the World Economic Forum, Gail Whiteman and colleagues warn that melting ice caps will impact on agriculture, insurance and tourism.View full blog post on the World Economic Forum website